Skip to main content
Premium Trial:

Request an Annual Quote

Selah Genomics Licenses UniConnect's LIMS to Support Clinical MDx Services

Premium

Selah Genomics has licensed UniFlow, UniConnect's laboratory information management system, to manage molecular and clinical data for its clinical diagnostic services business.

Michael Bolick, Selah's co-founder and CEO, said in a statement that his firm chose UniFlow because it met his firm's need for a "purpose-built" LIMS software solution, "not one that was just retrofitted for our arena."

Among other capabilities, UniFlow tracks and manages processes involving multiple steps and information types, such as samples, outputs, instruments, reagents, worker responsibilities, and requests. Also, users can customize the system to their needs and modify them as requirements change.

Besides Selah, UniFlow being used by Vivia Biotech, a Sergovia, Spain-based personalized medicine firm (BI 5/27/2011), and Dupont Pioneer (BI 5/3/2013).

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.